Skip to main content

Breast health

DCIS (ductal carcinoma in situ): what it is, symptoms, treatment and outlook

Ductal carcinoma in situ (DCIS) is an early, non-invasive form of breast cancer, sometimes called stage 0, where abnormal cells are contained inside the breast ducts. It is usually found on a screening mammogram and often causes no symptoms. Surgery is the main treatment, sometimes followed by radiotherapy or hormone therapy, and the aim is to stop it becoming invasive.

Last checked: 2026-10-18

Key facts

At a glance.

  • What it is

    Cancer Research UK says DCIS is an early breast cancer in which some cells in the lining of the breast ducts have started to turn into cancer cells. They are all inside the ducts and have not spread.

  • Stage 0

    In the number staging system DCIS is stage 0, and in TNM staging it is Tis N0 M0 (Cancer Research UK). It may also be called pre-invasive or non-invasive.

  • Usually no symptoms

    Macmillan says DCIS usually has no symptoms and is usually found through changes seen on a mammogram. A small number of people have a breast lump, nipple discharge or an eczema-like rash on the nipple.

  • How common

    Cancer Research UK says around 7,600 women are diagnosed with DCIS in the UK each year. Macmillan says 1 in 5 breast cancers found by screening are DCIS.

  • Not always invasive

    Macmillan says not every untreated DCIS will develop into invasive breast cancer, but it is not possible to tell for certain which cases will, so doctors usually advise treating it.

  • Main treatment

    Surgery is the main treatment. Macmillan says breast-conserving surgery (wide local excision) and mastectomy work equally well for treating DCIS.

  • Outlook

    Macmillan describes DCIS as not a life-threatening condition. Cancer Research UK says after a mastectomy DCIS almost never comes back.

What is DCIS?

Macmillan describes DCIS as the earliest changes to cells which might then become breast cancer. It says it is not a life-threatening condition, but treatment is usually recommended to stop it developing into breast cancer. Breast cancer usually starts in the cells lining the lobules, where milk is made, and the ducts that carry milk to the nipple. In DCIS the lining is replaced by abnormal cells, which are completely contained in the ducts and lobules and have not broken through their walls or spread into surrounding breast tissue.

Cancer Research UK explains that doctors may describe DCIS in different ways, including pre-invasive, non-invasive, ductal intraepithelial neoplasia (DIN), intraductal cancer and stage 0 breast cancer. DCIS and invasive breast cancer are not the same thing: in invasive breast cancer the cells have broken out of the ducts and spread into surrounding tissue, with a chance of reaching lymph nodes or other parts of the body.

Macmillan says that if DCIS is not treated, over time there may be more changes to the cells so that it spreads into the breast tissue around the ducts and becomes an invasive breast cancer. Not every untreated DCIS will do so, but because doctors cannot tell for certain which will, they usually advise treating it. Having DCIS also means a slightly higher risk of cancer elsewhere in the same breast or in the other breast.

How is DCIS treated?

Macmillan says a multidisciplinary team (MDT) of specialists meets to discuss the best treatment, and then your doctor or specialist nurse explains the options and side effects so you can decide together. The team needs to know the size of the DCIS, whether it is in one part of the breast, its grade and whether it has hormone receptors. The main treatment is surgery to remove the DCIS, and the aim is to remove it and reduce the risk of it developing into invasive cancer.

Cancer Research UK says surgery is the main treatment for DCIS and that you might have an area of the breast removed (breast-conserving surgery) or the whole breast (mastectomy). Your surgeon might recommend a particular operation or give you a choice, and some people prefer to keep as much of their breast as possible while others prefer the whole breast removed because it makes them feel more confident that the DCIS has gone.

Main treatments for DCIS (Macmillan and Cancer Research UK)
TreatmentWhat it involvesNotes
Breast-conserving surgery (wide local excision, WLE)Removes the area of DCIS and a border of healthy tissue (margin)The most common type of surgery; aims to keep as much of the breast and its shape as possible
MastectomyRemoves the whole breastMay be advised if the DCIS is large, there are several areas, or too much of the breast is affected for conserving surgery; reconstruction can be done at the time or later
Sentinel lymph node biopsyAbout 1 to 3 lymph nodes in the armpit removed and checkedUsually done with a mastectomy
RadiotherapyTreats the rest of the breast tissue after breast-conserving surgeryMacmillan says it is usually advised to reduce the risk of DCIS coming back; Cancer Research UK says it is for DCIS that looks very abnormal (high grade)
Hormone (endocrine) therapyTablets that lower oestrogen or stop it attaching to cellsOnly works for oestrogen receptor positive DCIS; Cancer Research UK says it is recommended for 5 years if you have breast conserving surgery, are oestrogen positive and do not have radiotherapy

Breast-conserving surgery or mastectomy?

Macmillan says a WLE and a mastectomy work equally well for treating DCIS, so your surgeon and breast care nurse may ask you to decide which operation feels right. After surgery the edges of the removed tissue are examined; if DCIS cells are close to or at the edge, another operation may be needed. If you have a mastectomy, you will usually also have a sentinel lymph node biopsy, and you may be able to have a new breast shape made during the operation or later.

Cancer Research UK says that after a mastectomy DCIS almost never comes back, while for women who just have the area of DCIS removed the chance is a bit higher. It stresses that your doctor can give you more information about the chance in your case.

What are the symptoms of DCIS?

Macmillan says DCIS usually has no symptoms and is usually found through changes seen on a mammogram taken as part of the NHS breast screening programme. A small number of people go to their GP with symptoms and are referred for a mammogram. Cancer Research UK lists the possible symptoms: a lump in the breast, discharge from the nipple which might be blood stained, and a rash on the nipple that may be red and scaly.

Macmillan says if you have Paget's disease, a condition affecting the skin of the nipple that causes redness, discharge or bleeding and sometimes itching, you may also have DCIS and will usually be referred for a mammogram. Always see your GP if you notice any breast symptoms.

How is DCIS diagnosed?

Macmillan says that in the UK women and people assigned female at birth aged 50 to 70 are invited to NHS breast screening every 3 years, and DCIS is now diagnosed much more often than it used to be, with 1 in 5 screen-detected breast cancers (20%) being DCIS. If a mammogram shows changes you are referred to a breast clinic for further tests, which may include more mammograms focused on the area (from different angles or with magnification), a breast ultrasound including the lymph nodes in the armpit, and a biopsy, where a small piece of tissue or sample of cells is checked for cancer cells.

Cancer Research UK says doctors use the grade and stage to decide treatment. Grade is how abnormal the cells look under a microscope: low (more slowly growing), intermediate or high (more quickly growing). Doctors think high-grade DCIS is more likely to come back after treatment and to spread into surrounding breast tissue.

Follow-up after DCIS treatment

Macmillan says that after treatment you will have yearly mammograms for 5 years (of your other breast if you had a mastectomy). After 5 years, if you are 50 or over, you usually have mammograms through the NHS breast screening programmes, and younger women usually continue with yearly mammograms until they reach 50. Cancer Research UK says check-ups depend on your situation and that everyone who has had treatment for early breast cancer should have a copy of a written care plan. Contact your healthcare team between appointments if you notice a symptom or are worried.

Macmillan also notes that your treated breast will look and feel different, that your cancer doctor or nurse will usually advise against contraception that contains hormones, and that treatment can affect your sex life and body image. Difficulties often improve slowly, and you can ask your nurse for support.

What causes DCIS?

Macmillan says the exact cause of DCIS is unknown, but certain risk factors increase the chance of developing it, and they are similar to those for invasive breast cancer. Having one or more risk factors does not mean you will definitely get DCIS, and having none does not mean you will not. DCIS is likely to be caused by a combination of risk factors rather than one. Cancer Research UK adds that one clinical trial found some evidence of a genetic cause of DCIS and invasive breast cancer but that more research is needed.

Is all DCIS treated? Research into low-risk DCIS

Cancer Research UK says researchers are trying to find out whether people with low or intermediate risk DCIS need to have treatment at all, and points to clinical trials. For now Macmillan says doctors usually advise treating DCIS because they cannot yet identify which cases would become invasive. Ask your breast team whether any trials you could join are relevant to your situation.

When to see a doctor

See your GP if you notice a breast lump, discharge from the nipple (especially if blood stained), a red scaly rash on the nipple or any other breast change. Macmillan advises always seeing your GP with any breast symptom. If you have had DCIS, contact your breast care team promptly if you notice changes in either breast between check-ups. Call 999 for severe symptoms such as heavy bleeding or sudden severe breathlessness.

NHS and private pathways

Most DCIS is found through NHS breast screening or a GP referral and treated in an NHS breast unit by a multidisciplinary team, with a breast care nurse as a key contact. The usual route to a breast clinic is via screening recall or a GP referral. Some people have private mammograms, consultations or surgery; treatment follows the same principles, and the pathology and plan should still be discussed by a breast MDT and shared with your GP. Macmillan and Cancer Research UK provide information and nurse helplines for people with DCIS.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • What is DCIS?

    Ductal carcinoma in situ is an early breast cancer in which abnormal cells are contained within the milk ducts and have not spread into surrounding tissue, according to Cancer Research UK and Macmillan. It is also called stage 0 or pre-invasive breast cancer.

  • Is DCIS cancer?

    Cancer Research UK calls DCIS an early breast cancer, and Macmillan describes it as the earliest changes to cells that might become breast cancer. It is non-invasive, which means it has not spread out of the ducts, and Macmillan says it is not life threatening.

  • What are the symptoms of DCIS?

    Usually none. Macmillan says it is usually found on a screening mammogram. A small number of people have a breast lump, nipple discharge which might be blood stained, or a red, scaly rash on the nipple. The section "What are the symptoms of DCIS?" above has more detail.

  • How is DCIS treated?

    Surgery is the main treatment, either breast-conserving surgery (wide local excision) or mastectomy, followed in many cases by radiotherapy after breast-conserving surgery and sometimes hormone therapy, according to Macmillan and Cancer Research UK. The section "Is all DCIS treated? Research into low-risk DCIS" above has more detail.

  • Do I need radiotherapy after DCIS surgery?

    Macmillan says that after breast-conserving surgery your cancer doctor will usually advise radiotherapy to reduce the risk of DCIS coming back. Cancer Research UK says it may be offered when the cells look very abnormal (high grade). Your team will discuss benefits and risks.

  • Will DCIS become invasive breast cancer?

    Not always. Macmillan says not every untreated DCIS will develop into invasive breast cancer, but doctors cannot tell for certain which will, so they usually advise treatment. Cancer Research UK says high-grade DCIS is more likely to spread into surrounding breast tissue.

  • Can DCIS come back?

    Yes, but it is uncommon after a mastectomy. Cancer Research UK says after mastectomy DCIS almost never comes back, and the chance is a bit higher if only the area of DCIS is removed. Hormone therapy and radiotherapy can reduce the risk.

  • Is a mastectomy better than a lumpectomy for DCIS?

    Macmillan says a wide local excision and a mastectomy work equally well for treating DCIS, so the choice depends on the size and position of the DCIS and what you prefer. Mastectomy is advised if the DCIS is large, in several areas or too extensive.

  • How often will I have mammograms after DCIS?

    Macmillan says you will have yearly mammograms for 5 years. After that, if you are 50 or over, you usually go back to NHS breast screening. Younger women usually continue yearly mammograms until they reach 50. The section "Follow-up after DCIS treatment" above has more detail.

  • How common is DCIS?

    Cancer Research UK says around 7,600 women are diagnosed with DCIS in the UK each year, and it is very rare in men. Macmillan says 1 in 5 breast cancers found by screening are DCIS. The section "Is all DCIS treated? Research into low-risk DCIS" above has more detail.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-18, next review 2027-10-18.